Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo
- 10 October 2010
- journal article
- Published by Elsevier in Vision Research
- Vol. 51 (1), 93-100
- https://doi.org/10.1016/j.visres.2010.10.008
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Loss of VLDL Receptor Activates Retinal Vascular Endothelial Cells and Promotes AngiogenesisInvestigative Opthalmology & Visual Science, 2009
- Role of the Multifunctional DNA Repair and Redox Signaling Protein Ape1/Ref-1 in Cancer and Endothelial Cells: Small-Molecule Inhibition of the Redox Function of Ape1Antioxidants and Redox Signaling, 2008
- Ranibizumab for neovascular age-related macular degenerationAmerican Journal of Health-System Pharmacy, 2008
- Expression of VLDLR in the Retina and Evolution of Subretinal Neovascularization in the Knockout Mouse Model’s Retinal Angiomatous ProliferationInvestigative Opthalmology & Visual Science, 2008
- Overview of Progress in the Epidemiology of Age-Related Macular DegenerationOphthalmic Epidemiology, 2007
- Retinal angiogenesis in development and diseaseNature, 2005
- The Intracellular Localization of APE1/Ref-1: More than a Passive Phenomenon?Antioxidants and Redox Signaling, 2005
- The subtle side to hypoxia inducible factor (HIFα) regulationEuropean Journal of Biochemistry, 2003
- Going APE over ref-1Mutation Research/DNA Repair, 2000
- Evidence that the bifunctional redox factor / AP endonuclease Ref-1 is an anti-apoptotic protein associated with differentiation in the developing retinaCell Death & Differentiation, 2000